$1.83 -0.05 (-2.66%)
11/24/2009 4:00 PM

AVANIR Pharmaceuticals (AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Featured Broker Partners